CERS
Cerus Corporation
NASDAQ: CERS · HEALTHCARE · MEDICAL DEVICES
$2.03
+5.73% today
Updated 2026-04-30
Market cap
$396.73M
P/E ratio
—
P/S ratio
1.93x
EPS (TTM)
$-0.08
Dividend yield
—
52W range
$1 – $3
Volume
1.7M
Cerus Corporation (CERS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-7.58%
Operating margin
-1.11%
ROE
-25.70%
ROA
-2.57%
Debt/equity
1.60x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $35.58M | $-4.78M | 95.67% | -26.64% | -13.43% |
| 2007 | $11.04M | $-45.30M | 52.66% | -390.85% | -410.21% |
| 2008 | $16.51M | $-29.18M | 41.43% | -184.95% | -176.78% |
| 2009 | $17.98M | $-24.14M | 30.04% | -132.54% | -134.22% |
| 2010 | $23.11M | $-16.91M | 47.87% | -69.06% | -73.18% |
| 2011 | $33.04M | $-16.98M | 43.91% | -48.19% | -51.39% |
| 2012 | $36.70M | $-15.92M | 43.82% | -47.15% | -43.38% |
| 2013 | $39.66M | $-43.34M | 43.01% | -71.36% | -109.28% |
| 2014 | $36.50M | $-38.57M | 41.99% | -121.49% | -105.65% |
| 2015 | $34.22M | $-55.87M | 31.44% | -178.46% | -163.25% |
| 2016 | $37.18M | $-62.91M | 45.42% | -165.26% | -169.18% |
| 2017 | $43.57M | $-60.59M | 48.29% | -132.05% | -139.06% |
| 2018 | $60.91M | $-57.56M | 48.06% | -90.28% | -94.51% |
| 2019 | $74.65M | $-71.24M | 55.23% | -88.72% | -95.44% |
| 2020 | $91.92M | $-59.86M | 55.23% | -63.46% | -65.12% |
| 2021 | $130.86M | $-54.38M | 51.49% | -37.40% | -41.55% |
| 2022 | $162.05M | $-42.83M | 53.75% | -21.03% | -26.43% |
| 2023 | $156.37M | $-37.49M | 55.25% | -19.22% | -23.98% |
| 2024 | $180.27M | $-20.92M | 55.21% | -7.89% | -11.60% |
| 2025 | $206.13M | $-15.63M | 54.47% | -4.21% | -7.58% |